The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

Suzetrigine, the candidate drug by Vertex Pharmaceuticals, would be the first selective sodium channel blocker approved ... meaning the proposed rule could be released any day. “As the FDA ...

The proposed rule, if finalized, would establish a compliance date of ... to releasing the FOP proposed rule, FDA also issued a final rule updating the definition of the implied nutrient content ...

The FDA banned the controversial red dye no. 3, which gives food and drinks a bright, cherry red color. The ban is a response to a 2022 petition ... drugs have a compliance date of Jan. 18 ...

Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click ...

The variants are used in the AvertD test, which the FDA approved in December 2023 to predict ... the VA's Million Veteran Program from 1992 to 2022. They also tried to determine whether the ...

which was first approved by the FDA in 1969. FDA bans use of Red No. 3 dye in food, drinks The FDA's Jan. 15 decision was in response to a 2022 petition from health groups and activists that cited ...

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

The U.S. Food and Drug Administration (FDA) is taking a stronger approach toward supporting health goals in 2025 and beyond by setting the tone ...

it does not mean these tobacco products are safe, nor are they 'FDA approved,'" the agency cautioned in its statement on Thursday. "There is no safe tobacco product; youth should not use tobacco ...